Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Plaque Psoriasis”

540 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 540 results

Large-scale testing (Phase 3)Study completedNCT02445807
What this trial is testing

The Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis

Who this might be right for
Chronic Stable Plaque Psoriasis
Promius Pharma, LLC 265
Not applicableStudy completedNCT04428411
What this trial is testing

Study To Evaluate The Impact Of Difficult To Treat Sites On Biological Response In Moderate-To-Severe Plaque Psoriasis(PsO).

Who this might be right for
Plaque Psoriasis
Pfizer 486
Testing effectiveness (Phase 2)Study completedNCT03421197
What this trial is testing

Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)

Who this might be right for
Psoriasis
Dr. Reddy's Laboratories Limited 426
Post-approval studies (Phase 4)Study completedNCT03055494
What this trial is testing

Study to Explore the Effect of Secukinumab, Compared to Placebo, on Fat Tissue and Skin in Plaque Psoriasis Patients

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 102
Not applicableLooking for participantsNCT06382051
What this trial is testing

Modifying PEST for Psoriatic Arthritis Screening

Who this might be right for
Plaque PsoriasisPsoriatic Arthritis
Novartis Pharmaceuticals 502
Post-approval studies (Phase 4)Study completedNCT00512187
What this trial is testing

Moderate Weight Loss Makes Obese Patients With Severe Chronic Plaque Psoriasis Responsive to Sub-Optimal Dose of Cyclosporine: an Investigator Blinded, Controlled, Randomized Clinical Trial

Who this might be right for
Chronic Plaque PsoriasisObesity
Universita di Verona
Testing effectiveness (Phase 2)Looking for participantsNCT07251998
What this trial is testing

Efficacy and Safety of ICP-332 Versus Placebo in Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Beijing InnoCare Pharma Tech Co., Ltd. 172
Post-approval studies (Phase 4)Looking for participantsNCT03987763
What this trial is testing

A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis

Who this might be right for
Psoriasis
Bausch Health Americas, Inc. 45
Not applicableStudy completedNCT00678470
What this trial is testing

Open Label Study of Alefacept Injections to Patients With Moderate to Severe Psoriasis

Who this might be right for
Moderate to Severe Psoriasis
University of California, San Francisco 18
Testing effectiveness (Phase 2)Study completedNCT04999839
What this trial is testing

Study of NDI-034858 in Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Takeda 259
Large-scale testing (Phase 3)Ended earlyNCT02527421
What this trial is testing

DFD01 Spray HPA Axis Suppression Study in Adolescent Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Primus Pharmaceuticals 3
Early research (Phase 1)Looking for participantsNCT06888193
What this trial is testing

Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

Who this might be right for
Moderate to Severe Plaque PsoriasisPsoriatic ArthritisAxial Spondyloarthritis+1 more
UCB Biopharma SRL 20
Post-approval studies (Phase 4)WithdrawnNCT04614298
What this trial is testing

Brodalumab (KHK4827) in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Kyowa Kirin Co., Ltd.
Large-scale testing (Phase 3)Looking for participantsNCT06842199
What this trial is testing

Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis Patients
Beijing InnoCare Pharma Tech Co., Ltd. 383
Large-scale testing (Phase 3)Study completedNCT01970488
What this trial is testing

Study to Compare Efficacy and Safety of ABP 501 and Adalimumab (HUMIRA®) in Adults With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Amgen 350
Large-scale testing (Phase 3)Study completedNCT02698475
What this trial is testing

An Efficacy, Safety, and Pharmacokinetics Study of Subcutaneously Administered Ustekinumab in the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Pediatric Participants Greater Than or Equal to 6 to Less Than 12 Years of Age

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 44
Large-scale testing (Phase 3)Study completedNCT02016105
What this trial is testing

Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira

Who this might be right for
Plaque Type Psoriasis
Sandoz 465
Large-scale testing (Phase 3)Study completedNCT00747344
What this trial is testing

Trial to Look at the Safety and Effectiveness of Ustekinumab in Korean and Taiwanese Subjects With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Psoriasis
Centocor, Inc. 121
Post-approval studies (Phase 4)Study completedNCT00791765
What this trial is testing

Moderate to Severe Plaque Psoriasis With Scalp Involvement

Who this might be right for
Psoriasis
Amgen 124
Testing effectiveness (Phase 2)Study completedNCT03230292
What this trial is testing

Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Adult Patients With Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
UCB Biopharma SRL 43
Next Page